When and why should my API be a new crystalline polymorph, amorphous, a co-crystal, or an alternative salt?
Teva api Adopts New Nitrosamine Regulations
Navigating China’s API Regulations
Creatively using co-crystals to produce alternative generic products
Teva api Offers New API Sterilization Services
A global API supplier that understands the API industry!
Trends in the API industry that you should be aware of (2019)
Why changes in the API manufacturing landscape is great news for Teva api
Last site inspections
- Feb 17-21, 2020 Teva API had a successful inspection in the Teva api Italy, Rho site by AIFA
- Feb 11-14, 2020 Teva API had a successful inspection in the Teva api India, Malanpur site by PMDA
- Jan 20-24, 2020 Teva API had a successful inspection in the Teva api Croatia site by USFDA
Last regulatory updates
- Sep 13, 2021 CEP
- Jun 13, 2021 CEP
- May 01, 2021 EU DMF